$IOVA While a going-in-alone outcome is very possible for Iovance Biotherapeutics, and there are plenty of fish in the big pharma sea should a buyout occur, one can't help but smile tenderly at this statement. ☺️
🤍 Thank you to Fosco on StockTwits for yet another great share.